Table 3.
Antibacterial activity of Satureja intermedia C.A.Mey EO.
| Microorganisms | S. intermedia EO | Vancomycin 4 | ||
|---|---|---|---|---|
| MIC 2 (mg/mL) | MBC 3 (mg/mL) | MIC (mg/mL) | MBC (mg/mL) | |
| Streptococcus mutants (ATCC 25175) | 4.2 ± 0.0 1 | 20 ± 0.0 | 0.0025 | 0.014 ± 0.0 |
| S. mutants (ATCC 31383) | 4.6 ± 0.3 | 20 ± 0.0 | 0.0025 | 0.014 ± 0.0 |
| S. mutants (ATCC 35668) | 5.1 ± 0.0 | 20 ± 0.0 | 0.0025 | 0.014 ± 0.0 |
| Streptococcus salivarius (ATCC 13419) | 12.5 ± 0.2 | 38.4 ± 0.2 | 0.044 | 0.065 ± 0.0 |
| S. salivarius (ATCC 9222) | 11.4 ± 0.0 | 36.5 ± 0.0 | 0.044 | 0.065 ± 0.0 |
| Enterococcus faecalis (ATCC 29212) | 8.9 ± 0.0 | 25.5 ± 0.3 | 0.036 | 0.045 ± 0.0 |
| E. faecalis (ATCC11700) | 9.2 ± 0.6 | 25.2 ± 0.1 | 0.036 | 0.045 ± 0.0 |
| Staphylococcus aureus (ATCC 25923) | 6.5 ± 0.0 | 19.4 ± 0.1 | 0.012 | 0.011 ± 0.0 |
| S. aureus (ATCC 700698) | 7.7 ± 0.4 | 20.4 ± 0.1 | 0.012 | 0.011 ± 0.0 |
1 Data are expressed as mean ± SD of 2 MIC (minimum inhibitory concentration) and 3 MBC (minimum bactericidal concentration) of S. intermedia EO and 4 reference drug (vancomycin).